BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 177 filers reported holding BLUEBIRD BIO INC in Q4 2021. The put-call ratio across all filers is 1.00 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,429 | -82.1% | 1,457 | -80.6% | 0.00% | – |
| Q2 2023 | $24,711 | +919.9% | 7,511 | +885.7% | 0.00% | – |
| Q1 2023 | $2,423 | -89.2% | 762 | -76.5% | 0.00% | – |
| Q4 2022 | $22,462 | -55.1% | 3,246 | -59.0% | 0.00% | – |
| Q3 2022 | $50,000 | +400.0% | 7,918 | +234.9% | 0.00% | – |
| Q2 2022 | $10,000 | -75.6% | 2,364 | -72.1% | 0.00% | – |
| Q1 2022 | $41,000 | -12.8% | 8,486 | +82.9% | 0.00% | – |
| Q4 2021 | $47,000 | +176.5% | 4,639 | +413.2% | 0.00% | – |
| Q3 2021 | $17,000 | -92.5% | 904 | -87.3% | 0.00% | – |
| Q2 2021 | $227,000 | +19.5% | 7,106 | +12.7% | 0.00% | – |
| Q1 2021 | $190,000 | +245.5% | 6,303 | +393.2% | 0.00% | – |
| Q4 2020 | $55,000 | -46.6% | 1,278 | -33.3% | 0.00% | – |
| Q3 2020 | $103,000 | -62.8% | 1,915 | -57.9% | 0.00% | -100.0% |
| Q2 2020 | $277,000 | +12.1% | 4,552 | -15.3% | 0.00% | 0.0% |
| Q1 2020 | $247,000 | -2.0% | 5,377 | +87.9% | 0.00% | 0.0% |
| Q4 2019 | $252,000 | -32.8% | 2,862 | -29.9% | 0.00% | 0.0% |
| Q3 2019 | $375,000 | -28.4% | 4,081 | -1.0% | 0.00% | 0.0% |
| Q2 2019 | $524,000 | -19.3% | 4,121 | -0.0% | 0.00% | -50.0% |
| Q1 2019 | $649,000 | +118.5% | 4,123 | +38.0% | 0.00% | +100.0% |
| Q4 2018 | $297,000 | -53.0% | 2,987 | -31.0% | 0.00% | -50.0% |
| Q3 2018 | $632,000 | -0.3% | 4,331 | +7.3% | 0.00% | 0.0% |
| Q2 2018 | $634,000 | -8.0% | 4,038 | +0.0% | 0.00% | 0.0% |
| Q1 2018 | $689,000 | +11383.3% | 4,037 | +12922.6% | 0.00% | – |
| Q4 2017 | $6,000 | -77.8% | 31 | -84.5% | 0.00% | – |
| Q3 2017 | $27,000 | -65.8% | 200 | -82.8% | 0.00% | – |
| Q3 2016 | $79,000 | +3850.0% | 1,165 | +2673.8% | 0.00% | – |
| Q1 2016 | $2,000 | -99.5% | 42 | -99.0% | 0.00% | -100.0% |
| Q3 2015 | $369,000 | -49.2% | 4,313 | +0.0% | 0.00% | -33.3% |
| Q2 2015 | $726,000 | +18.6% | 4,312 | -14.8% | 0.00% | +50.0% |
| Q1 2015 | $612,000 | +738.4% | 5,063 | +533.7% | 0.00% | – |
| Q4 2014 | $73,000 | – | 799 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sessa Capital IM, L.P. | 1,834,965 | $35,066,000 | 1.72% |
| Birchview Capital, LP | 84,000 | $1,605,000 | 1.09% |
| ARMISTICE CAPITAL, LLC | 2,472,000 | $47,240,000 | 0.80% |
| EcoR1 Capital, LLC | 802,507 | $15,336,000 | 0.53% |
| Parametrica Management Ltd | 36,919 | $706,000 | 0.53% |
| Bain Capital Life Sciences Investors, LLC | 538,179 | $7,239,000 | 0.45% |
| APPLETON GROUP, LLC | 19,495 | $373,000 | 0.32% |
| MANGROVE PARTNERS IM, LLC | 175,587 | $3,355,000 | 0.30% |
| Quinn Opportunity Partners LLC | 230,100 | $4,397,000 | 0.28% |
| PDT Partners, LLC | 171,700 | $3,281,000 | 0.24% |